INS and muscular atrophy: Moreover, skeletal muscle, as the primary site of insulin-stimulated glucose uptake, has been implicated as a major driver of systemic insulin resistance; patients with skeletal muscle atrophy often develop insulin resistance, resulting in lower glucose utilization, which in turn stimulates fat synthesis and storage (37).